These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6980945)

  • 41. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. I. Identification of functions for the T cell surface molecules Ly-6C and Thy-1.
    Johnson R; Lancki DW; Fitch FW
    J Immunol; 1993 Sep; 151(6):2986-99. PubMed ID: 8104217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helper T-cell type 1 or type 2 function of xeno-MHC-restricted T-cell clones in a direct xenoantigen recognition.
    Iida Y; Iwata H; Mori Y; Takagi H; Nitta T; Kanetake K; Umeda Y; Hirose H
    Transpl Immunol; 2003; 11(2):169-73. PubMed ID: 12799200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biology of the T cell.
    Blue ML; Schlossman SF
    Prog Clin Biol Res; 1986; 224():11-20. PubMed ID: 3099307
    [No Abstract]   [Full Text] [Related]  

  • 44. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 48. The identification and function of T cells, T-cell subsets, and their factors.
    Geha RS
    Birth Defects Orig Artic Ser; 1983; 19(3):9-14. PubMed ID: 6228274
    [No Abstract]   [Full Text] [Related]  

  • 49. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell differentiation.
    Miller RG
    Int J Cell Cloning; 1986; 4 Suppl 1():26-38. PubMed ID: 2943826
    [No Abstract]   [Full Text] [Related]  

  • 51. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggregation of MHC class I molecules on a CD8+ alphabeta T cell clone specifically inhibits non-antigen-specific lysis of target cells.
    Caparrós E; de Heredia AB; Carpio E; Sancho D; Aguado E; Aparicio P
    Eur J Immunol; 2004 Jan; 34(1):47-55. PubMed ID: 14971029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A human large granular lymphocyte clone with natural killer-like activity and T cell-like surface markers.
    Sheehy MJ; Quintieri FB; Leung DY; Geha RS; Dubey DP; Limmer CE; Yunis EJ
    J Immunol; 1983 Feb; 130(2):524-6. PubMed ID: 6600239
    [No Abstract]   [Full Text] [Related]  

  • 58. Class II major histocompatibility complex molecules regulate the development of the T4+T8- inducer phenotype of cultured human thymocytes.
    Blue ML; Daley JF; Levine H; Schlossman SF
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8178-82. PubMed ID: 2933749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The human T cell receptor: analysis with cytotoxic T cell clones.
    Reinherz EL; Meuer SC; Schlossman SF
    Immunol Rev; 1983; 74():83-112. PubMed ID: 6195086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A common trigger molecule (TrgS) for secretion of lytic factor is expressed on cells that participate in non-MHC restricted cellular cytotoxicity.
    Stein-Streilein J; Guffee J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):105-7. PubMed ID: 2784880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.